Boston Scientific to acquire cardiac health solutions provider Preventice
The acquisition of Preventice will provide Boston Scientific with a foothold in the high-growth ambulatory electrocardiography space
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 Jan 21
The acquisition of Preventice will provide Boston Scientific with a foothold in the high-growth ambulatory electrocardiography space
20 Jan 21
Thermo Fisher will additionally pay up to $100m in cash, after reaching certain milestones post-closing of the transaction
15 Jan 21
ADAPT-PD Global Study is designed to evaluate the safety and efficacy of automated therapy that responds to brain…
13 Jan 21
PBGI is focused on non-controlling equity investments in small- to medium-sized public and large-scale private companies developing clinical-stage…
12 Jan 21
The test is designed to evaluate mild traumatic brain injury (TBI) (concussion) and offer results within 15 minutes…
06 Jan 21
The acquisition of Biotheranostics will allow Hologic to leverage commercial capabilities and expertise in molecular diagnostics automation
30 Dec 20
If the discussions are fruitful, Moderna is expected to supply 40 million doses of mRNA-1273 vaccine in South…
21 Dec 20
The acquisition will combine Philips’ in-hospital patient monitoring capabilities with BioTelemetry’s monitoring capabilities outside the hospital
16 Dec 20
FDA authorised Ellume Covid-19 Home Test for non-prescription home use in symptomatic and asymptomatic individuals
11 Dec 20
Ensono developed the secure cloud-based infrastructure for PIONEER hub, in collaboration with Microsoft, HDR UK, the University of…